
    
      Up to 50 subjects will be enrolled into one of two cohorts of this study in a ratio of 1:1
      (Treatment: Placebo Control). Subjects will be screened and randomized into one of two
      parallel cohorts.

        -  Treatment (N = up to 25): Subjects will be enrolled and receive daily NONI treatment for
           14 days with a follow-up visit on Day 28 post randomization.

        -  Placebo (N = up to 25): Subjects will be enrolled and receive a placebo for 14 days with
           a follow-up visit on Day 28 post randomization.
    
  